Palisade Bio, Inc. Gains 52.38%
Wed, Oct 01, 2025 at 08:28 PM
Palisade Bio, Inc. (PALI:NASDAQ) shot up at $1.31, a gain of 52.4%. On Wed, Oct 01, 2025, PALI:NASDAQ touched a New 2-Week High of $1.31. The stock appeared on our News Catalysts scanner on Wed, Oct 01, 2025 at 01:26 PM in the 'PUBLIC OFFERING' category. From Wed, Sep 17, 2025, the stock recorded 70.00% Up Days and 72.73% Green Days
The stock spiked on Wed, Oct 01, 2025 at $1.81 with a volume of 166M+.
About Palisade Bio, Inc. (PALI:NASDAQ)
Palisade Bio Inc is a late-stage biopharma company.
Top 10 Gainers:
- Ryvyl Inc. (RVYL:NASDAQ), 71.62%
- Palisade Bio, Inc. (PALI:NASDAQ), 52.38%
- SRAX, Inc. (SRAX:NASDAQ), 50%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- Ambipar Emergency Response (AMBI:NYSEMKT), 44.98%
- Argo Blockchain plc (ARBK:NASDAQ), 39.37%
- Rail Vision Ltd. (RVSN:NASDAQ), 35.34%
- Toro Corp. (TORO:NASDAQ), 34.19%
- Angel Studios Inc. Class A (ANGX:NYSE), 33.56%
- Latch, Inc. (LTCH:NASDAQ), 33.33%